Scientists probe hidden risk of common rosacea pill
NCT ID NCT05296837
Summary
This study aims to understand if a common low-dose pill for eye rosacea (40mg doxycycline) actually changes the bacteria in the gut and eye or increases antibiotic resistance, even though it's not officially classified as an antibiotic. Researchers will compare 50 adults with ocular rosacea taking either the low dose, a higher antibiotic dose, or a placebo for 8 weeks. The main goal is to gather knowledge about the safety of this long-term treatment approach, not primarily to test how well it treats symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIMICROBIAL RESISTANCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California, San Farncisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.